Literature DB >> 21806583

Variation of female prolactin levels with menopausal status and phase of menstrual cycle.

Melissa J Tanner1, Narelle C Hadlow, Robert Wardrop.   

Abstract

BACKGROUND: Prolactin is not commonly recognised as a hormone that changes significantly within the menstrual cycle or after menopause. The aim of this study was to determine the degree of variability of prolactin in these physiological states.
METHOD: Prolactin levels obtained from 6540 subjects between January 2006 and November 2008 were divided into five groups: men, postmenopausal women and premenopausal women in follicular/non-cycling, ovulatory and luteal phases. The median and 97.5th centile was determined for each group. The 97.5th centile was used to define the upper limit of prolactin.
RESULTS: The prolactin median and upper limits were not significantly different in men and postmenopausal women. They were significantly higher in premenopausal women compared to men and postmenopausal women. Within premenopausal women, the prolactin median and upper limits were significantly higher in ovulatory phase compared to follicular/non-cycling and luteal phases and in luteal phase compared to follicular/non-cycling phase.
CONCLUSIONS: Prolactin levels varied significantly throughout the menstrual cycle, and the utility and accuracy of prolactin testing may be improved by applying specific reference intervals for each phase of the menstrual cycle. Alternatively, a single reference interval could be used if prolactin is only measured in the follicular phase, well before midcycle. Prolactin levels in postmenopausal women and men were not significantly different, and a common prolactin reference interval may be appropriate. Further studies to confirm formal reference ranges for these groups may be clinically helpful.
© 2011 The Authors. Australian and New Zealand Journal of Obstetrics and Gynaecology © 2011 The Royal Australian and New Zealand College of Obstetricians and Gynaecologists.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21806583     DOI: 10.1111/j.1479-828X.2011.01321.x

Source DB:  PubMed          Journal:  Aust N Z J Obstet Gynaecol        ISSN: 0004-8666            Impact factor:   2.100


  14 in total

Review 1.  The treatment of hyperprolactinemia in postmenopausal women with prolactin-secreting microadenomas: cons.

Authors:  Alexander T Faje; Anne Klibanski
Journal:  Endocrine       Date:  2014-06-03       Impact factor: 3.633

2.  Neurobiological changes mediating the effects of chronic fluoxetine on cocaine use.

Authors:  Eileen K Sawyer; Jiyoung Mun; Jonathon A Nye; Heather L Kimmel; Ronald J Voll; Jeffrey S Stehouwer; Kenner C Rice; Mark M Goodman; Leonard L Howell
Journal:  Neuropsychopharmacology       Date:  2012-03-21       Impact factor: 7.853

3.  Cabergoline Withdrawal Before and After Menopause: Outcomes in Microprolactinomas.

Authors:  Rita Indirli; Emanuele Ferrante; Elisa Sala; Claudia Giavoli; Giovanna Mantovani; Maura Arosio
Journal:  Horm Cancer       Date:  2019-04-18       Impact factor: 3.869

4.  Circulating prolactin levels and risk of epithelial ovarian cancer.

Authors:  Tess V Clendenen; Alan A Arslan; Anna E Lokshin; Mengling Liu; Eva Lundin; Karen L Koenig; Franco Berrino; Goran Hallmans; Annika Idahl; Vittorio Krogh; Annekatrin Lukanova; Adele Marrangoni; Paola Muti; Brian M Nolen; Nina Ohlson; Roy E Shore; Sabina Sieri; Anne Zeleniuch-Jacquotte
Journal:  Cancer Causes Control       Date:  2013-02-03       Impact factor: 2.506

Review 5.  The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review.

Authors:  J Peuskens; L Pani; J Detraux; M De Hert
Journal:  CNS Drugs       Date:  2014-05       Impact factor: 5.749

6.  Physical activity does not alter prolactin levels in post-menopausal women: results from a dose-response randomized controlled trial.

Authors:  Darren R Brenner; Yibing Ruan; Andria R Morielli; Kerry S Courneya; Christine M Friedenreich
Journal:  Eur Rev Aging Phys Act       Date:  2017-07-13       Impact factor: 3.878

7.  Association of psoriasis severity with serum prolactin, thyroid hormones, and cortisol before and after treatment.

Authors:  Reza M Robati; Parviz Toossi; Mohammad Rahmati-Roodsari; Sara Khalilazar; Ehsan Abolhasani; Nastaran Namazi; Shima Younespour
Journal:  ScientificWorldJournal       Date:  2013-10-28

8.  Rotating night shifts too quickly may cause anxiety and decreased attentional performance, and impact prolactin levels during the subsequent day: a case control study.

Authors:  Yu-San Chang; Hsiang-Lan Chen; Yu-Hsuan Wu; Chung-Yao Hsu; Ching-Kuan Liu; Chin Hsu
Journal:  BMC Psychiatry       Date:  2014-08-05       Impact factor: 3.630

9.  Establishing reference intervals for sex hormones on the analytical platforms Advia Centaur and Immulite 2000XP.

Authors:  Andreas N Schüring; Reinhard Kelsch; Grzegorz Pierściński; Jerzy Roch Nofer
Journal:  Ann Lab Med       Date:  2016-01       Impact factor: 3.464

10.  Altered Spontaneous Brain Activity in Women During Menopause Transition and Its Association With Cognitive Function and Serum Estradiol Level.

Authors:  Lemin He; Wei Guo; Jianfeng Qiu; Xingwei An; Weizhao Lu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-11       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.